Mesothelin-Specific Immune Responses and Targeted Immunotherapy for Mesothelin-Expressing Tumors

被引：1

作者：

Einama, Takahiro ^{[1
,4
]}

Kawamata, Futoshi ^{[1
]}

Kamachi, Hirofumi ^{[1
]}

Nishihara, Hiroshi ^{[2
]}

Homma, Shigenori ^{[1
]}

Matsuzawa, Fumihiko ^{[1
]}

Mizukami, Tatsuzo ^{[1
]}

Konishi, Yuji ^{[1
]}

Kamiyama, Toshiya ^{[1
]}

Yamamoto, Junji ^{[4
]}

Taketomi, Akinobu ^{[1
]}

Todo, Satoru ^{[3
]}

机构：

[1] Hokkaido Univ, Grad Sch Med, Dept Gen Surg, Sapporo, Hokkaido 0608638, Japan

[2] Natl Hosp Org, Hokkaido Canc Ctr, Dept Pathol, Sapporo, Hokkaido 0030804, Japan

[3] St Marys Hosp, Res Inst, Kurume, Fukuoka 8308558, Japan

[4] Natl Def Med Coll, Dept Surg, 3-2 Namiki, Tokorozawa, Saitama 3598513, Japan

来源：

EBIOMEDICINE | 2017年 / 24卷

关键词：

GASTRIC-CANCER; ERC/MESOTHELIN; ADENOCARCINOMA;

D O I：

10.1016/j.ebiom.2017.09.033

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：16 / 17

页数：2

共 50 条

[41] 99mTc-A1 as a Novel Imaging Agent Targeting Mesothelin-Expressing Pancreatic Ductal Adenocarcinoma
Montemagno, Christopher
Cassim, Shamir
Trichanh, Dimitry
Savary, Clara
Pouyssegur, Jacques
Pages, Gilles
Fagret, Daniel
Broisat, Alexis
Ghezzi, Catherine
CANCERS, 2019, 11 (10)
[42] Engineered Fn3 protein has targeted therapeutic effect on mesothelin-expressing cancer cells and increases tumor cell sensitivity to chemotherapy
Sirois, Allison R.
Deny, Daniela A.
Li, Yanxuan
Fall, Yacine D.
Moore, Sarah J.
BIOTECHNOLOGY AND BIOENGINEERING, 2020, 117 (02) : 330 - 341
[43] Preclinical Evaluation of Mesothelin-Specific Ligands for SPECT Imaging of Triple-Negative Breast Cancer
Montemagno, Christopher
Bacot, Sandrine
Ahmadi, Mitra
Kerfelec, Brigitte
Baty, Daniel
Debiossat, Marlene
Soubies, Audrey
Perret, Pascale
Riou, Laurent
Fagret, Daniel
Broisat, Alexis
Ghezzi, Catherine
JOURNAL OF NUCLEAR MEDICINE, 2018, 59 (07) : 1056 - 1062
[44] An open-label, phase II study of intravenous anetumab ravtansine, an anti-mesothelin antibody drug conjugate, in pretreated mesothelin-expressing advanced pancreatic cancer.
Chokshi, Saurin
Hochster, Howard S.
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
[45] Dendritic cells adenovirally-transduced with full-length mesothelin cDNA elicit mesothelin-specific cytotoxicity against pancreatic cancer cell lines in vitro
Miyazawa, Motoki
Iwahashi, Makoto
Ojima, Toshiyasu
Katsuda, Masahiro
Nakamura, Masaki
Nakamori, Mikihito
Ueda, Kentaro
Naka, Teiji
Hayata, Keiji
Iida, Takeshi
Yamaue, Hiroki
CANCER LETTERS, 2011, 305 (01) : 32 - 39
[46] Dendritic Cells Adenovirally-Transduced With Full-Length Mesothelin cDNA Elicit Mesothelin-Specific Cytotoxicity Against Pancreatic Cancer Cell Lines In Vitro
Miyazawa, M.
Iwahashi, M.
Ojima, T.
Katsuda, M.
Nakamura, M.
Mikihito, N.
Yamaue, H.
PANCREAS, 2012, 41 (07) : 1162 - 1162
[47] Development of anti-human mesothelin chimeric antigen receptor (CAR) messenger RNA (mRNA) transfected peripheral blood mononuclear cells (CARMA) for the treatment of mesothelin-expressing cancers
Hung, Chien-Fu
Xu, Xuequn
Li, Linhong
Ma, Ying
Jin, Qiu
Viley, Angelia
Allen, Cornell
Natarajan, Pachai
Shivakumar, Rama
Peshwa, Madhusudan V.
Emens, Leisha A.
CANCER RESEARCH, 2017, 77
[48] Tumor-directed radiation and the immunotoxin SS1P in the treatment of mesothelin-expressing tumor xenografts
Hassan, Raffit
Williams-Gould, Juanita
Steinberg, Seth M.
Liewehr, David J.
Yokokawa, Junko
Tsang, Kwong Y.
Surawski, Robert J.
Scott, Tamalee
Camphausen, Kevin
CLINICAL CANCER RESEARCH, 2006, 12 (16) : 4983 - 4988
[49] Mesothelin-Targeted CARs: Driving T Cells to Solid Tumors
Morello, Aurore
Sadelain, Michel
Adusumilli, Prasad S.
CANCER DISCOVERY, 2016, 6 (02) : 133 - 146
[50] Radiolabeling, selection and evaluation of indium-111 labeled anti-mesothelins in human mesothelin-expressing xenografts
Hsu, W.
Cheng, K.
Chang, Y.
Ho, C.
Yu, C.
Yang, S.
Hsu, H.
Yang, C.
Chang, C.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S681 - S681

← 1 2 3 4 5 →